DR. IMADUDDIN MOHAMMED

M. Ch. (Magister Chirurgiae), MS (Masters of Surgery), M.B.B.S

Specialization: Peritoneal Surface Malignancies, Breast Cancer, Ovarian Cancer, Colorectal Cancer

Experience: 6+ years

Language: Telugu,Hindi,English

Location: Hyderabad

Timings: 10AM - 5PM

Dr. Mohammed Imaduddin is a Consultant Surgical Oncologist at CION Cancer Clinics.
He completed his MBBS (2012) and MS in General Surgery (2017) from Osmania Medical College, followed by an M.Ch in Surgical Oncology (2021) from AIIMS Bhubaneswar. He is a FEBS – Fellow of the European Board of Surgery in Surgical Oncology (2022) awarded by the European Union of Medical Specialists (UEMS), and an ESSO Fellow in Peritoneal Surface Malignancy, HIPEC, and PIPAC (2023) under Prof. Dr. Beate Rau at the Department of Special Surgical Oncology, MHH, University Hospital of Hannover, Germany. He has also attended advanced training on Perioperative Management during CRS and HIPEC for Peritoneal Surface Malignancy at Charité University Hospital, Berlin. With his international fellowships and specialized expertise, Dr. Imaduddin is dedicated to offering cutting-edge surgical oncology care.

M.B.B.S. | 2012 | Osmania Medical College
MS (Masters of Surgery) | 2017 | Osmania Medical College
M. Ch. (Magister Chirurgiae) | 2021 | AIIMS Bhubaneshwar
FEBS Fellow of European Board of Surgery in Surgical Oncology | 2022 | European Union of Medical Specialists (UEMS) – Surgical Oncology Division
ESSO Fellow in Peritoneal Surface Malignancy, HIPEC, and PIPAC | 2023 | Under the guidance of Prof. Dr. Beate Rau, Department of Special Surgical Oncology, MHH, University Hospital of Hannover, Germany.
Attended the course on Perioperative Management during CRS and HIPEC in the Treatment of Peritoneal Surface Malignancy, Charité University Hospital, Berlin.

Peritoneal Surface malignancies
Gastric cancer
Colorectal Cancer
Ovarian Cancer

Research
AIIMS Bhubaneshwar | 2018 - 2020 | Thesis during residency program under the guidance of Prof. Madhabananda Kar "Post-Operative Complications in Gastric Cancer Surgery – A Prospective Longitudinal Surgery"
Osmania Medical College| 2015 – 2017 | Thesis during residency program under the guidance of Dr. Sri Hari Rao "Prevention and Prophylactic Management of Alcohol Withdrawal Syndrome during post-operative period in emergency surgical cases – A Prospective Study"
Osmania Medical College| 2008 |Short Term Studentship (STS) awarded by Indian Council of Medical Research (ICMR) for the project "A Comparative Study of Conventional and Automated Methods of Blood Culture"
Publications
COVIDSurg Collaborative. (2021). Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: An international, prospective, cohort study. The Lancet. Oncology, 22(11), 1507–1517. https://doi.org/10.1016/S1470-2045(21)00493-9
Muduly DK, Imaduddin M, Sultania M, Houghton T, G PKC, Rao PB, Mitra JK, Behera BK, Mohakud S, Kar M. Prophylactic Drain Versus No Drain in Curative Gastric Cancer Surgery-A Randomized Controlled Trial. J Gastrointest Surg. 2022 Oct 24. doi: 10.1007/s11605-022-05480-0. PMID: 36279088
Imaduddin, M., Ayyanar, P., Sultania, M., Muduly, D., Sable, M. N., Naik, S., Mohanty, S., & Kar, M. (2021). Primary malignant giant cell tumor of the sternum. Autopsy & Case Reports, 11, e2021281. https://doi.org/10.4322/acr.2021.281
Imaduddin, M., Sultania, M., Vigneshwaran, B., Muduly, D. K., & Kar, M. (2021a). Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic. Oral Oncology, 114, 105069.https://doi.org/10.1016/j.oraloncology.2020.105069
Imaduddin, M., Sultania, M., Vigneshwaran, B., Muduly, D. K., & Kar, M. (2021b). Psychosocial Factors in an Oral Cancer Survivor Leading to Delay in Seeking Help. Oral Oncology, 105438. https://doi.org/10.1016/j.oraloncology.2021.105438
Kar, M., Imaduddin, M., Muduly, D. K., Sultania, M., Houghton, T., Panigrahi, M. K., Misra, S., Patra, S., & Mohakud, S. (2021). Minimally invasive esophagectomy: Preservation of arch of Azygos vein in prone position. Journal of Minimal Access Surgery, 17(3), 405. https://doi.org/10.4103/jmas.JMAS_267_20
Muduly, D. K., Sultania, M., Imaduddin, M., & Kar, M. (2021). Providing cancer patients with COVID-19 free surgical pathway by two test 7 days apart preoperative protocol (TTS protocol). Journal of Surgical Oncology, 123(5), 1199– 1200. https://doi.org/10.1002/jso.26401
Muduly DK, Colney L, Kar M, Imaduddin M, Patra S, Sultania M, G S, Swain PK, Sahoo B, Mohakud S, Nayak HK, Panigrahi MK. Effect of Preoperative Body Mass Index on Postoperative and Long-Term Outcomes in an East Indian Gastric Cancer Cohort. J Gastrointest Cancer. 2024 Feb 5. doi: 10.1007/s12029-024- 01018-6 .
Ayyanar P, Mitra S, Imaduddin M, Muduly DK. Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman - An uncommon occurrence. Indian J Pathol Microbiol. 2024 Jan-Mar;67(1):189-191. doi: 10.4103/ijpm.ijpm_1207_21.
N, H., K, V. K., & Imaduddin, M. (2020). Procalcitonin Ratio of Post-Operative Day 1 and Day 2 Procalcitonin Values to Predict the Surgical Outcome in Severe Necrotizing Soft Tissue Infections. World Journal of Surgery and Surgical Research, 3(1). https://www.surgeryresearchjournal.com/abstract.php?aid=7413
Sultania, M., Imaduddin, M., S. V. Deo, S., Kar, M., K. Muduly, D., Kumar, S., Sharma, A., Mishra, A., K. D. Majumdar, S., K. Adhya, A., & K. Parida, D. (2022). Role of metronomic therapy for advanced oral cancers and predictors of response: Multi-institutional feasibility study. Head & Neck, 44(1), 104–112. https://doi.org/10.1002/hed.26904
Sultania, M., Muduly, D., Balasubiramaniyan, V., Imaduddin, M., .R, E., Chaudhary, I., Singh, A., Jain, A., Colney, L., Ambre, S., Dipin, K. R., & Kar, M. (2020). Impact of the initial phase of COVID‐19 pandemic on surgical oncology services at a tertiary care center in Eastern India. Journal of Surgical Oncology, 122. https://doi.org/10.1002/jso.26140
Sultania, M., Muduly, D., Imaduddin, M., & Kar, M. (2020). Oral Cancer Surgery and COVID pandemic – Metronomic Therapy shows a promising role while awaiting surgery. Oral Oncology, 106, 104814. https://doi.org/10.1016/j.oraloncology.2020.104814
Sultania M, Imaduddin M, Muduly DK, Majumdar SKD, Adhya AK, Parida DK, Kar M. Metronomic Therapy in Palliation of Oral Cancer Patients-A Home Based Approach at the End of Life. Gulf J Oncolog. 2022 Sep;1(40):24-28. PMID: 36448067.
Imaduddin M, Swati Priya D, Mamidala V, et al. (August 05, 2025) Unraveling the Conundrum: A Rare Case of Mucinous Cystadenoma in the Uterus. Cureus 17(8): e89387. doi:10.7759/cureus.89387

FREQUENTLY ASKED QUESTIONS

You Have Questions? We Have Answers!

Who are the best cancer doctors in Hyderabad at CION Network?

If you're searching for the best cancer doctors in Hyderabad, the CION Network connects you with highly experienced oncologists who specialize in medical oncology, surgical oncology, and radiation therapy. We have experts in treating various types of cancers, including head and neck cancer, breast cancer, gynecological cancer, blood cancer, and more. Our goal is to provide personalized cancer treatment by matching you with the most suitable specialist for your condition.

How can I find the top oncologist in Hyderabad?

The CION Network includes 20+ cancer care centres, with 15+ centres in and around Hyderabad, staffed with some of the top oncologists in Hyderabad. Whether you need a second opinion, treatment planning, or ongoing care, our expert oncologists are available to guide your journey. Contact us to find the right specialist for you.

Do you have the best medical oncologists in Hyderabad?

Yes, the CION Network has a team of top medical oncologists in Hyderabad, with expertise in various types of cancers. Our specialists work together through tumour board discussions to evaluate all treatment options, ensuring patients receive comprehensive and effective cancer care.

Which is the best cancer hospital in Hyderabad under the CION Network?

All centres within the CION Network follow stringent protocols and uphold high-quality care, making them some of the best cancer hospitals in Hyderabad. Our focus on patient comfort, expert consultations, and supportive care ensures a smooth experience across any of our Hyderabad-based centres.

Is CION Network a specialized oncology hospital or a general hospital?

The CION Network is a dedicated oncology hospital chain, focused exclusively on cancer diagnosis, treatment, and care. With 15+ expert oncologists and 20+ centres across Telangana and Andhra Pradesh, we provide specialized services including teleconsultations for patients in remote areas.

What types of cancers are treated at CION Network centres?

The CION Network offers comprehensive cancer treatment across a wide spectrum, including lung cancer, breast cancer, oral cancer, prostate cancer, gastrointestinal cancer, blood cancer, and gynecological cancers. To check if your condition is covered under our support programs or insurance-linked care, please contact us directly.

Can I get a cancer second opinion at CION Network?

Yes, we provide second opinions for all cancer types. You can visit any of our centres in person or opt for a video consultation with our top oncologists in Hyderabad and surrounding regions. Booking a second opinion is simple—just get in touch with us to schedule your appointment.

How can I find a cancer hospital near me through CION Network?

With 20+ cancer clinics, including 15+ conveniently located in Hyderabad, the CION Network makes it easy to find a cancer hospital near you. We also offer online consultations for added flexibility and accessibility. Contact us to connect with your nearest CION centre.

DR. IMADUDDIN MOHAMMED

Consult with Cancer Specialists

Take the First Step Towards Recovery— Reach Out Today!

FREQUENTLY ASKED QUESTIONS

Begin your healing journey with us today.

Our SERVICES

Quick Links

CION Cancer Clinics